Available Webinar Registrations

CITI Program Replay: Aggregative Safety Assessment Planning and IND Safety Reporting

Webinar Date: June 22, 2026

Webinar Time: 02:00 pm

This previously released webinar discusses that according to the U.S. Food and Drug Administration (FDA), IND safety reporting needs to be supported by ongoing systematic assessment of the product’s safety data from all sources. This webinar examines the Aggregate Safety Assessment Planning (ASAP) process as a mechanism for meeting this guidance. The ASAPlanning document (updated over time), along with its Safety Surveillance Plan (SSP) appendix, provides comprehensive product-level safety assessment planning, which guides the systematic ongoing review of safety data from all completed and continuing clinical trials throughout development.

First Name

Last Name

Email Address

Organization

Please share your question for the presenter(s) here:

May we contact you about new CITI Program content and services after the webinar?

Yes

Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy.